Delova Biotech, a biotechnology and health care startup, was founded in 2017. The company has recently secured a significant CNY50.00M in a Venture Round investment on 21 September 2020 from prominent investors including Legend Capital and Indaco Capital.
Delova Biotech’s focus on biotechnology and health care indicates its commitment to addressing critical global health challenges through innovative solutions. The recent investment from respected venture capital firms underscores the industry's confidence in the company's potential for growth and impact within the biotech and health care sectors.